Categories: News

Loopback Analytics Surpasses 30 Clients on the Loopback Platform

DALLAS, June 23, 2021 /PRNewswire/ — Loopback Analytics is thrilled to announce the milestone of surpassing 30 clients on the Loopback platform. Thanks to growing demand for dynamic analytics to help improve patient outcomes and drive growth, Loopback has had the opportunity to earn key partnerships with reputable health systems across the nation.

After shifting its focus to health sy­­stem pharmacies in 2017, Loopback Analytics has grown to be the leader in for data-driven solutions for health system and academic medical center specialty and ambulatory pharmacy programs. As an organization, Loopback believes that health system specialty pharmacy programs are uniquely positioned to provide superior care for patients considering their relationship with prescribers as part of the integrated delivery network as well as access to the clinical records for the patients they serve. The Loopback platform enables health systems to unlock impactful data insights out of their EMR to effectively identify growth opportunities of high-value medications, ensure access to medications, improve total cost of care, and demonstrate the value their pharmacy program provides to the integrated delivery network.

Loopback provides data analytics for more than 30 health system clients, 220+ hospitals, thousands of clinics and 50 million patient lives. “We are excited about this growth, not only as a company but also as an industry leader,” said Neil Smiley, CEO at Loopback Analytics. “Loopback has made huge strides in the development of our solutions, and we are confidently committed to continue empowering our clients and partners to win in specialty pharmacy.”

MEDIA CONTACT: JD Smiley, jdsmiley@loopbackanalytics.com, 214-552-3023

View original content to download multimedia:http://www.prnewswire.com/news-releases/loopback-analytics-surpasses-30-clients-on-the-loopback-platform-301318722.html

SOURCE Loopback Analytics

Staff

Recent Posts

NervGen Pharma Announces Proposed Amendment to Warrants

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

4 hours ago

MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…

6 hours ago

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…

6 hours ago

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…

6 hours ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…

6 hours ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…

6 hours ago